• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Cramer: 5 Companies the Market Is Ready to Forgive

For these companies, things aren't as bad as we thought.
By JIM CRAMER
Dec 23, 2015 | 06:17 AM EST
Stocks quotes in this article: CVS, TGT, GIS, CELG, COST

You never know whether it is just an era of good feelings at the dawn of 2016 or if there's just a sense that things aren't bad as we thought.

That's what forgiveness mode is about, and we are seeing forgiveness all over the place. Last week, CVS Health (CVS), which is being held in the Trifecta Stocks portfolio, came out at an analyst meeting and raised the low end of its estimate range, while giving you a 21% increase in the dividend. It was an outstanding day, but Goldman Sachs used the occasion to downgrade the stock -- it may have been coincidence, but it did have a huge impact, and the stock got rocked from $97 to $94. I came out swinging and said this was ridiculous and it was a terrific opportunity to buy, because the company is doing better than expected and it is one of the best retailers out there.

On Tuesday, it roared back above $97 to $98 on no real news. It probably isn't done either, as there is so much good news flow that is going to come out from its tie-up with Action Alerts PLUS portfolio name Target (TGT) and its pharmacy benefit manager business.

It should never have been down to begin with.

Or, how about General Mills (GIS)? The company reported a miss on the top and bottom lines, and growth is continuing to slow despite the Annie's acquisition and the changeover to more natural and organic staples plus the sale of Green Giant. U.S. retail sales fell 4%. Now, that's not international, that's domestic. No strong dollar issues.

But the company continues to buy back a tremendous amount of stock -- about 30 million shares out of a total of 593 million outstanding. CEO Ken Powell is talking up some of the big changes in the line-up that could reverse some of the slowing trends. He gave a very vigorous presentation that made you feel you should own the stock, not sell it, and although it fell immediately from $59 to $56, I figured it would just be a matter of time before it is forgiven. It didn't even give you much time, as it is $0.80 under the level at which it was when it reported.

How about Celgene (CELG)? Can you believe how many people have written this company's stock off because of generic woes and patent challenges? In the meantime, it is expected to earn $7.20 in 2017, making the stock sell at a discount to the average stock on that number. Why not? If a patent challenge is going to win or a key drug like revlimid is going off patent, then the 2017 number is a stretch. But all of that's over, now that Celgene made a deal last night that gives it seven more years of exclusivity. Now the 2017 number is for real and the stock is free to soar.

What else could be next to rebound? I thought that Costco (COST) got the short end of the stick when it reported not that long ago, and a close reading of the transcript of the call explained away any weakness. The stock fell from $168 to $158, but now it is starting to mount a comeback, and I suspect that it can clear the mid $160s from its $161 perch. Quality retailers like that don't stay down very long.

Finally, one more: Accenture (ACN). Here's a stock that went from $109 to $101 on what was supposed to be a bad "miss" when it reported last week. The company's got a huge overseas business that made the earnings come in weaker than what was expected. This is such a high quality company and all of the lines of business did quite well, but everyone is so used to seeing this company blow away the quarter that its double-digit overseas sales didn't count as much as it should have.

Now, both Costco and Accenture have hair on them, certainly more than CVS, but both the retailer and the consultant company are doing so much better than General Mills, it's silly to compare them.

I think that these two will be the next to be forgiven, and the market's already started the  process of rehabilitation that is expected when you get terrific companies with one-off sales that happen only a few times a year.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long TGT, COST.

TAGS: Investing | U.S. Equity

More from Investing

This Bull Market Is Not an Equal Opportunity Employer

James "Rev Shark" DePorre
Apr 15, 2021 4:32 PM EDT

We're seeing great action for major funds that are holding big-cap names, but downright lousy action for individual traders.

TSMC's Guidance Did Nothing to Spoil the Fun for Chip Stocks

Eric Jhonsa
Apr 15, 2021 4:20 PM EDT

Though the chip manufacturing giant is lower post-earnings, there's a lot to like about its revenue and capex guidance, as well as other commentary it shared.

Jim Cramer: We've Got a Boom ... and a Bust

Jim Cramer
Apr 15, 2021 3:36 PM EDT

Let's look at this impossible move on the market -- and why health care could be coming off life support.

The Technical Condition of Amarin Corp. Remains Weak

Bruce Kamich
Apr 15, 2021 2:45 PM EDT

Let's review the charts and indicators.

Keysight Technologies: Bullish Fundamentals and Charts

Bruce Kamich
Apr 15, 2021 2:07 PM EDT

TK

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login